Financials

  • Market Capitalization 4.39 B
  • Employee 838
  • Founded 2014
  • CEO Mark Crossley
  • Website www.indivior.com
  • Headquarter Delaware, United States
  • FIGI BBG01ZTXFLQ6
  • Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
15.63
売上高対価格比率
3.02

Indivior Pharmaceuticals, Inc. - Common Stock

Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.

ニュース